Effectiveness of short-course quinine and singledose sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria in Mpumalanga province, South Africa
E. Athan et al., Effectiveness of short-course quinine and singledose sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria in Mpumalanga province, South Africa, S AFR MED J, 91(7), 2001, pp. 592-594
Introduction. Quinine therapy for 7 days remains the mainstay for treating
hospitalised malaria cases in South Africa. However, limited resources, inc
luding available beds and staff, often result in early discharge of non-sev
ere cases, with quinine tablets for outpatient use. The effectiveness of sh
orter course quinine therapy coupled with a long-acting antimalarial drug h
as never been established in Africa, in particular in a population without
malaria immunity.
Methods. A study was conducted to evaluate the effectiveness of a 3-day cou
rse of therapy with quinine sulphate (10 mg/kg 8-hourly) followed by a sing
le dose of sulfadoxine-pyrimethamine (SP) according to weight category, bef
ore discharge, for 133 hospitalised patients with uncomplicated Plasmodium
falciparum malaria at Shongwe Hospital, Mpumalanga province, between Februa
ry and July 1998. Study endpoints included clinical recovery and parasitolo
gical cure, including polymerase chain reaction (PCR) 42 days after initiat
ing treatment.
Results. One hundred and thirty of 131 patients (99%) successfully followed
up for 42 days demonstrated clinical and parasitological cure. The remaini
ng patient, who had evidence of a recrudescent infection on PCR, was 1 of 6
1 patients who were still parasitaemic on discharge from hospital.
Conclusion. The abbreviated course of quinine therapy coupled with a single
dose of SP for the treatment of nonsevere hospitalised cases of Rfalcipari
on malaria, in an area with demonstrated low levels of SP resistance, was h
ighly effective. This approach has potential benefits, including reduced du
ration of hospitalisation, fewer quinine-associated adverse events and prot
ection against the evolution of quinine resistance by limiting unsupervised
quinine therapy in the community. It may, however, be prudent to document
a negative blood film before discharge from hospital.